Altria moving toward entering US marijuana market

Altria (owner of Philip Morris) has made two moves to get ready to enter the US marijuana market. It registered to lobby on marijuana commercialization in Virginia and has submitted two US patents for cannabis vaporization devices.

According to the report in Cannabis Wire, “Altria supports the federal legalization of cannabis under an appropriate regulatory framework. As a stakeholder in this industry we intend to work with policymakers and regulators in support of a transparent, responsible, and equitable operating environment for the sale of cannabis…” This is exactly the same rhetoric that Altria has used for decades in working to preempt effective public health regulation with pro-industry rules.

The tobacco industry’s interest in the marijuana business. Philip Morris and other tobacco companies have been exploring getting into the cannabis business since the 1970s. The industry’s efforts cooled with the emergence of the War and Drugs that would put them cross-ways with the federal government. Now that cannabis legalization is moving forward with broad public support, Altria, along with other major corporate interests, is moving to lay the foundation to take over the cannabis market.

A particular problem is that the debate to date has been dominated by business interests with public health largely sitting on the sidelines. The current period of policy fluidity has created opportunities for health interests to influence policies and laws that are being put in place for decades to come. But to have such impact, they need to engage.

My basic policy principle: Treat marijuana like tobacco: Legal but discouraged with strong protections for nonusers.

Here are several papers we have published based on this principle that get into policy details, including specific legislative and regulatory language to legalize cannabis within a public health — as opposed to a business — framework:

Published by Stanton Glantz

Stanton Glantz is a retired Professor of Medicine who served on the University of California San Francisco faculty for 45 years. He conducts research on tobacco and cannabis control and cardiovascular disease/

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: